Saba Capital Management’s Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share CLAA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-94,399
Closed -$5.78K 918
2022
Q4
$5.78K Buy
94,399
+1,251
+1% +$97 ﹤0.01% 844
2022
Q3
$15K Buy
+93,148
New +$12.8K ﹤0.01% 979

Saba Capital Management's CLAA.WS Position: Q1 2023 in Review

Saba Capital Management sold out of Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share (CLAA.WS) in Q1 2023, closing a stake of 94,399 shares — an estimated $5.78K sold.

Saba Capital Management first reported a position in CLAA.WS in Q3 2022 and held it in 2 quarters. The position peaked at $15K in Q3 2022. 0 funds tracked by Wall St. Rank hold CLAA.WS as of Q1 2023.

  • Saba Capital Management reported no remaining Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position as of Q1 2023 after selling out during the quarter.
  • Saba Capital Management sold 94,399 Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share shares in Q1 2023, an estimated $5.78K.
  • Saba Capital Management first reported a position in Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in Q3 2022 and held it in 2 quarters.
  • Saba Capital Management's Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position peaked at $15K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share as of Q1 2023.

Based on Saba Capital Management's 13F filing for Q1 2023, filed 15 May 2023.